#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
In this episode, the podcast explores the exciting world of GLP-1 agonists like Ozempic and Mounjaro. The hosts discuss how these medications work, their effectiveness, potential side effects, and their impact on body composition. With growing public interest, they highlight the rapid developments in our understanding of these drugs since their last chat, stressing the need to stay updated with the latest clinical insights.
